Welcome to visit Zhongnan Medical Journal Press Series journal website!
Zhongnan Medical Journal Press
Series of Journals
Center for Evidence-Based and Translational Medicine of Wuhan University
The title
The title
The keywords
The author
Submit
Home
About us
Journal Introduction
Chief Editor
Editorial Committee
Author Center
Submission Guide
Assignment Agreement
ConflictofInterest
Articles
Subscribe
Copyright
Contact us
Draft submission system
Author login
Author register
Reviewer login
Editor login
Home
Articles
Vol 35,2026 No.7
The title
The title
The keywords
The author
New Online
Vol 35,2026
Vol 34,2025
Vol 33,2024
Vol 32,2023
No.7
No.6
No.5
No.4
No.3
No.2
No.1
Contents
Vol 35,2026 No.7
Date of publication: July 15, 2026
Get cover
Get contents
Prev
Vol 35,2026 No.6
Guide on Methodological Standards in Pharmacoepidemiology in China (2nd edition) and their series interpretation (19): tool systems and methodological paradigms for common data model-based data analysis
WU Yunxiao
NIE Xiaolu
ZHENG Yongqi
WANG Conghui
WU Jiarui
SUN Yexiang
SONG Haibo
ZHAN Siyan
SUN Feng
2026,35(7):721-731
Pharmacoepidemiology
Methodology
Guideline
Common data model
Real world evidence
Details
Download
Mobile
Influencing factors for unfavorable outcomes of doxycycline therapy in children with macrolide-resistant Mycoplasma pneumoniae pneumonia
GAO Yufeng
WU Qiong
LIN Zhi
2026,35(7):732-737
Doxycycline
Children
Macrolide-resistant
Mycoplasma pneumoniae pneumonia
Clinical outcome
Risk factors
Details
Download
Mobile
Efficacy of popliteal sciatic nerve block versus total intravenous anesthesia in diabetic foot surgery and analysis of influencing factors for wound healing
YANG Yue
PENG Junbo
LU Xinlei
2026,35(7):738-746
Diabetic foot
Popliteal sciatic nerve block
Intravenous anesthesia
Wound healing
Hemodynamics
Risk factors
Details
Download
Mobile
Long-term efficacy, safety, and risk stratification for hyperkalemia associated with finerenone in patients with diabetic kidney disease
XIE Yang
LI Lin
HAN Wenxia
2026,35(7):747-756
Finerenone
Diabetic kidney disease
Real-world study
Linear mixed model
Urinary albumin-to-creatinine ratio
Risk stratification
Details
Download
Mobile
Effects of enhanced recovery after surgery intervention assisted with Bacillus licheniformis on postoperative recovery time in patients undergoing colorectal cancer surgery
WANG Feifei
LU Xiaoyue
XU Dafang
2026,35(7):757-764
Enhanced recovery after surgery
Bacillus licheniformis
Colorectal cancer
Postoperative recovery time
Perioperative nursing
Details
Download
Mobile
Clinical efficacy of Tianqi Jiangtang capsule combined with empagliflozin in newly diagnosed type 2 diabetes mellitus patients
SHI Jin
PEI Zijuan
ZHANG Dan
CHEN Dan
WANG Dandan
ZHANG Li
SHI Kaiyue
WANG Dan
XIE Muya
YAN Ying
2026,35(7):765-772
Type 2 diabetes
Tianqi Jiangtang capsules
Empagliflozin
Blood sugar
Insulin
Details
Download
Mobile
Mining and analysis of adverse event signals for three novel lipoglycopeptide antibiotics based on the FAERS and WHO-VigiAccess database
ZHANG Yao
HU Zhansong
ZHAO Xiaoyun
CHEN Lijuan
2026,35(7):773-782
Lipoglycopeptide antibiotics
Adverse events
FAERS
WHO-VigiAccess
Signal mining
Details
Download
Mobile
Signal mining and analysis of adverse events of mirikizumab based on FAERS and EudraVigilance databases
YAN Xu
SUN Kun
JI Zhaoshuai
NIE Guangmeng
2026,35(7):783-791
Mirikizumab
Crohn's disease
Ulcerative colitis
FAERS
EudraVigilance
Signal mining
Details
Download
Mobile
Signal analysis of adverse events associated with pertuzumab-trastuzumab based on the FAERS database
ZHANG Juan
ZHU Haizhou
ZHANG Xue
GUO Kaixing
2026,35(7):792-799
Pertuzumab-trastuzumab
FAERS database
Adverse drug events
Signal mining
Reporting odds ratio
Pharmacovigilance
Details
Download
Mobile
Rapid health technology assessment of donanemab in the treatment of Alzheimer's disease
FAN Liming
DENG Tiantian
LAN Haiyue
DONG Yafen
QIU Yan
WANG Jian
2026,35(7):800-809
Donanemab
Alzheimer's disease
Efficacy
Safety
Cost-effectiveness
Rapid health technology assessment
Details
Download
Mobile
Meta-analysis of efficacy and safety of pertuzumab biosimilars versus original drug in the treatment of patients with HER2-positive breast cancer
GU Shilong
ZHANG Wenjing
GUO Hao
2026,35(7):810-817
Pertuzumab
Biosimilars
Original drug
HER2
Breast cancer
Efficacy
Safety
Meta-analysis
Details
Download
Mobile
Visual analysis of research hotspots, and trends on immunomodulatory effects of Tripterygium Wilfordii Hook.f.
XIAN Zicheng
CHEN Chao
JIANG Mengting
ZHOU Yinmin
LI Xue
YANG Ming
2026,35(7):818-826
Tripterygium wilfordii Hook.f.
Immune regulation
Bibliometrics
Citespace
Visual analysis
Details
Download
Mobile
Application of R language in pharmacovigilance signal detection
FU Yali
BA Lei
ZHOU Jian
SHI Wenhui
2026,35(7):827-835
Pharmacovigilance
Signal detection
Adverse reactions/events
R language
Details
Download
Mobile
Meropenem-induced drug hypersensitivity syndrome in children: a case report
LI Wen
LI Gen
JIANG Yongxian
HU Siqi
ZHANG Bo
2026,35(7):836-840
Meropenem
Drug hypersensitivity syndrome
Adverse reactions
Pseudomonas aeruginosa
Children
Details
Download
Mobile
Welcome to visit Zhongnan Medical Journal Press Series journal website!
Welcome to visit Zhongnan Medical Journal Press Series journal website!
